deferoxamine has been researched along with Shock, Cardiogenic in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " He was treated with a unique deferoxamine dosage schedule (25 mg/kg/h for 12 h/d x 3 d), mechanical ventilation, Swan-Ganz catheter monitoring, dopamine/nitroprusside therapy, blood product, bicarbonate, electrolyte and volume replacement." | 5.29 | Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine. ( Benson, B; Cheney, K; Gumbiner, C; Tenenbein, M, 1995) |
| " He was treated with a unique deferoxamine dosage schedule (25 mg/kg/h for 12 h/d x 3 d), mechanical ventilation, Swan-Ganz catheter monitoring, dopamine/nitroprusside therapy, blood product, bicarbonate, electrolyte and volume replacement." | 1.29 | Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine. ( Benson, B; Cheney, K; Gumbiner, C; Tenenbein, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JA | 1 |
| Tchantchaleishvili, V | 1 |
| Vidula, H | 1 |
| Cheney, K | 1 |
| Gumbiner, C | 1 |
| Benson, B | 1 |
| Tenenbein, M | 1 |
2 other studies available for deferoxamine and Shock, Cardiogenic
| Article | Year |
|---|---|
Cardiac Hemochromatosis Treated With Prolonged Extracorporeal Membrane Oxygenation Support and Chelation Therapy.
Topics: Adult; Cardiomyopathies; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Extracorporeal M | 2018 |
Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine.
Topics: Deferoxamine; Drug Administration Schedule; Drug Overdose; Gastric Lavage; Heart; Humans; Infant; In | 1995 |